Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 330 participants.
Also called NCT06603870
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 330 participants
- Registry
-
NCT06603870
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06603870. Allocation not applicable; no masking; primary purpose treatment. Start 2024-12-19 (actual); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
- Acronym
- STREAM-Line
- Condition
- Venous Thromboembolism
- Condition
- Cancer
- Condition
- Upper Extremity Deep Vein Thrombosis
- Condition
- Catheter-Related Infections
- Intervention (Drug)
- Anticoagulation Therapy
- Lead sponsor
- Ottawa Hospital Research Institute
Record details
- Record id
cardio:ct-nct06603870- Content hash
df4cd39e46829fb9e42c06ef7ce286dc29d00759409f9a6d058275d3d54d2abd